导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.59% | 221/354 |
| 近一周 | -2.28% | 217/356 |
| 近一月 | -3.47% | 216/362 |
| 近一季 | 2.35% | 92/362 |
| 近半年 | 5.14% | 183/358 |
| 近一年 | -1.31% | 197/349 |
| 近两年 | 27.33% | 195/314 |
| 近三年 | 46.76% | 112/244 |
| 成立以来 | 89.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-10.39% 269/360 |
6.43% 157/366 |
- - |
- - |
| 2025 | 29.27% 37/358 |
13.91% 106/340 |
14.41% 109/348 |
-1.51% 347/354 |
0.71% 152/358 |
| 2024 | 9.49% 191/329 |
6.47% 106/280 |
-2.68% 221/310 |
7.11% 133/318 |
-1.35% 162/329 |
| 2023 | 20.76% 69/275 |
10.59% 51/205 |
6.61% 86/230 |
-8.55% 220/262 |
12.00% 64/276 |
| 2022 | -13.45% 64/201 |
-12.22% 101/153 |
-12.51% 107/164 |
-6.06% 81/189 |
19.96% 12/202 |
| 2021 | 1.33% 59/150 |
4.13% 87/312 |
2.05% 185/328 |
-4.23% 182/358 |
-0.43% 70/151 |
| 2020 | 11.78% 37/103 |
-17.87% 207/280 |
22.97% 89/295 |
3.67% 117/299 |
6.77% 179/305 |
| 2019 | 19.14% 47/88 |
3.93% 198/258 |
8.50% 6/268 |
-0.87% 169/253 |
6.58% 129/266 |
| 2018 | -18.09% 62/79 |
- - |
- - |
- - |
-14.01% 161/241 |
| 2017 | 16.37% 37/69 |
- - |
- - |
- - |
- - |
| 2016 | 6.69% 25/59 |
- - |
- - |
- - |
- - |
| 2015 | 1.83% 18/49 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 华安德国(DAX)联接(QDII)A VS. 建信富时100指数(QDII)人民币A(539003) |